Sani H Kizilbash

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Tyrosine Kinase

Metastatic Colorectal Cancer

Top Venues

Neuro-oncology advances

JCO precision oncology

NPJ precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Ugur T Sener, Mahnoor Islam, Mason Webb, Sani H Kizilbash
Antiangiogenic exclusion rules in glioma trials: Historical perspectives and guidance for future trial design. Neuro-oncology advances 6 (1) (2024)
Ugur T Sener, Mahnoor Islam, Mason Webb, Sani H Kizilbash
Antiangiogenic exclusion rules in glioma trials: Historical perspectives and guidance for future trial design. Neuro-oncology advances 6 (1) (2024)
Cecile Riviere-Cazaux, Lucas P Carlstrom, Bryan J Neth, Ian E Olson, Karishma Rajani, Masum Rahman, Samar Ikram, Moustafa A Mansour, Bipasha Mukherjee, Arthur E Warrington, Susan C Short, Thomas von Zglinicki, Desmond A Brown, Sandeep Burma, Tamara Tchkonia, Marissa J Schafer, Darren J Baker, Sani H Kizilbash, James L Kirkland, Terry C Burns
An untapped window of opportunity for glioma: targeting therapy-induced senescence prior to recurrence. NPJ precision oncology 7 (1) (2023)
Cecile Riviere-Cazaux, Lucas P Carlstrom, Karishma Rajani, Amanda Munoz-Casabella, Masum Rahman, Ali Gharibi-Loron, Desmond A Brown, Kai J Miller, Jaclyn J White, Benjamin T Himes, Ignacio Jusue-Torres, Samar Ikram, Seth C Ransom, Renee Hirte, Ju-Hee Oh, William F Elmquist, Jann N Sarkaria, Rachael Ann Vaubel, Moses Rodriguez, Arthur E Warrington, Sani H Kizilbash, Terry C Burns
Blood-brain barrier disruption defines the extracellular metabolome of live human high-grade gliomas. Communications biology 6 (1) (2023)
Shannon P Fortin Ensign, Robert B Jenkins, Caterina Giannini, Jann N Sarkaria, Evanthia Galanis, Sani H Kizilbash
Translational Significance of CDKN2A/B Homozygous Deletion in IDH-Mutant Astrocytoma. Neuro-oncology (2022)
Jenny J Li, Xiaoling Zhang, Neil Sankar, Lynn Espiritu, Sanjeev Redkar, Guo-Liang Yu, Sani H Kizilbash
MET/HGF Coexpression as a Novel Predictive Biomarker for Response to MET Inhibitor Therapy in a Case of Psammomatous Melanotic Schwannoma. JCO precision oncology 6 (2022)